FGFR genetic alterations as a potential predictor of the sensitivity to CH5183284/Debio 1347, a selective FGFR inhibitor with a novel chemical scaffold

Poster available upon request, please contact our Communication Coordinator

Y. Nakanishi (1), N. Akiyama (1), T. Tsukaguchi (1), Y. Tachibana-Kondo (1), T. Fujii (1), K. Sakata (1), H. Sase (1), T. Isobe (2), Y. Sato (1), K. Morikami (2), H. Shindoh (1), T. Mio (1), H. Ebiike (1), N. Taka (2), Y. Aoki (1), N. Ishii (1)

Abstract – Presented at AACR 2014, San Diego, CA, USA

(1) Chugai pharmaceutical Co., Ltd, Kamakura, Japan

(2) Chugai pharmaceutical Co., Ltd., Gotemba, Japan